Clinical trial · Interventional
AYA OMGYES Sexual Health Study
Assessing the Impact of a Web-based Educational Program on the Sexual Health Outcomes of Young Adult Female Cancer Survivors ~ A Pilot Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to assess the impact of the web-based intervention OMGYES.com on sexual dysfunction in young adult (YA) female-bodied cancer survivors. This pilot trial seeks to evaluate the intervention's: * feasibility * acceptability * appropriateness. Researchers will utilize an active observation period to compare outcomes between those receiving the intervention immediately and those who haven't Participants will: * Complete online modules at home * Visit the clinic every 5 weeks for questionnaires
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Sexual Dysfunction | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| OMGYES.com | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Delayed Intervention
- description
- The delayed intervention group will initially undergo 5 weeks of active observation prior to intervention administration.
- interventionNames
- Other: OMGYES.com
- type
- EXPERIMENTAL
- label
- Immediate Intervention
- description
- The immediate intervention group will be administered the intervention at study enrollment.
- interventionNames
- Other: OMGYES.com
Primary outcomes (1)
- measure
- Feasibility of OMGYES.com using the Feasibility of Intervention Measure (FIM)
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 45 Years
Show eligibility criteria text
Inclusion Criteria: * Age 18 to 45 years * Diagnosis of cancer between the ages of 15 and 45 * Female genitalia, regardless of gender * Diagnosed with sexual dysfunction * Complete Remission and at least two months from a major treatment * Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial * Ability to participate in study modules and to respond to surveys * Ability to understand and the willingness to sign a written informed consent document Exclusion Criteria: * Patients receiving other investigational agents * Patients expected to be neutropenic or have a significantly high infection risk that would exclude them from vaginal penetration * Patients who are unable complete the study intervention or surveys
References
Publications (0)
Data not yet available